IMIDAZOPYRIDINE DERIVATIVES AS STING AGONISTS

Described herein, inter alia, are imidazopyridine derivatives (I), pharmaceutically acceptable salts and tautomers thereof, compounds, combinations and medicaments containing said compounds and processes for their preparation. In embodiments, the imidazopyridine derivatives can be used as regulators...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ZANG, Jingcun, HSIEH, Ming, TAO, Chunlin
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ZANG, Jingcun
HSIEH, Ming
TAO, Chunlin
description Described herein, inter alia, are imidazopyridine derivatives (I), pharmaceutically acceptable salts and tautomers thereof, compounds, combinations and medicaments containing said compounds and processes for their preparation. In embodiments, the imidazopyridine derivatives can be used as regulators of a stimulator of interferon genes (STING) and a related signal path thereof, and can effectively treat and/or relieve multiple types of diseases, including but not limited to malignant tumors, inflammations, autoimmune diseases, infectious diseases and as vaccine adjuvants. L'invention concerne, entre autres, des dérivés d'imidazopyridine (I), des sels pharmaceutiquement acceptables et des tautomères de ceux-ci, des composés, des associations et des médicaments contenant lesdits composés et des procédés pour leur préparation. Dans des modes de réalisation, les dérivés d'imidazopyridine peuvent être utilisés en tant que régulateurs d'un stimulateur de gènes d'interféron (STING) et d'une voie de signalisation associée de celui-ci, et peuvent traiter et/ou soulager de manière efficace de multiples types de maladies, y compris mais de façon non limitative des tumeurs malignes, des inflammations, des maladies auto-immunes, des maladies infectieuses et en tant qu'adjuvants de vaccins.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2022246597A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2022246597A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2022246597A13</originalsourceid><addsrcrecordid>eNrjZND19PV0cYzyD4gM8nTx9HNVcHEN8gxzDPEMcw1WcAxWCA7x9HNXcHT39_MMDgnmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBkZGRiZmppbmjobGxKkCAH8pJso</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>IMIDAZOPYRIDINE DERIVATIVES AS STING AGONISTS</title><source>esp@cenet</source><creator>ZANG, Jingcun ; HSIEH, Ming ; TAO, Chunlin</creator><creatorcontrib>ZANG, Jingcun ; HSIEH, Ming ; TAO, Chunlin</creatorcontrib><description>Described herein, inter alia, are imidazopyridine derivatives (I), pharmaceutically acceptable salts and tautomers thereof, compounds, combinations and medicaments containing said compounds and processes for their preparation. In embodiments, the imidazopyridine derivatives can be used as regulators of a stimulator of interferon genes (STING) and a related signal path thereof, and can effectively treat and/or relieve multiple types of diseases, including but not limited to malignant tumors, inflammations, autoimmune diseases, infectious diseases and as vaccine adjuvants. L'invention concerne, entre autres, des dérivés d'imidazopyridine (I), des sels pharmaceutiquement acceptables et des tautomères de ceux-ci, des composés, des associations et des médicaments contenant lesdits composés et des procédés pour leur préparation. Dans des modes de réalisation, les dérivés d'imidazopyridine peuvent être utilisés en tant que régulateurs d'un stimulateur de gènes d'interféron (STING) et d'une voie de signalisation associée de celui-ci, et peuvent traiter et/ou soulager de manière efficace de multiples types de maladies, y compris mais de façon non limitative des tumeurs malignes, des inflammations, des maladies auto-immunes, des maladies infectieuses et en tant qu'adjuvants de vaccins.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20221201&amp;DB=EPODOC&amp;CC=WO&amp;NR=2022246597A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20221201&amp;DB=EPODOC&amp;CC=WO&amp;NR=2022246597A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZANG, Jingcun</creatorcontrib><creatorcontrib>HSIEH, Ming</creatorcontrib><creatorcontrib>TAO, Chunlin</creatorcontrib><title>IMIDAZOPYRIDINE DERIVATIVES AS STING AGONISTS</title><description>Described herein, inter alia, are imidazopyridine derivatives (I), pharmaceutically acceptable salts and tautomers thereof, compounds, combinations and medicaments containing said compounds and processes for their preparation. In embodiments, the imidazopyridine derivatives can be used as regulators of a stimulator of interferon genes (STING) and a related signal path thereof, and can effectively treat and/or relieve multiple types of diseases, including but not limited to malignant tumors, inflammations, autoimmune diseases, infectious diseases and as vaccine adjuvants. L'invention concerne, entre autres, des dérivés d'imidazopyridine (I), des sels pharmaceutiquement acceptables et des tautomères de ceux-ci, des composés, des associations et des médicaments contenant lesdits composés et des procédés pour leur préparation. Dans des modes de réalisation, les dérivés d'imidazopyridine peuvent être utilisés en tant que régulateurs d'un stimulateur de gènes d'interféron (STING) et d'une voie de signalisation associée de celui-ci, et peuvent traiter et/ou soulager de manière efficace de multiples types de maladies, y compris mais de façon non limitative des tumeurs malignes, des inflammations, des maladies auto-immunes, des maladies infectieuses et en tant qu'adjuvants de vaccins.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZND19PV0cYzyD4gM8nTx9HNVcHEN8gxzDPEMcw1WcAxWCA7x9HNXcHT39_MMDgnmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBkZGRiZmppbmjobGxKkCAH8pJso</recordid><startdate>20221201</startdate><enddate>20221201</enddate><creator>ZANG, Jingcun</creator><creator>HSIEH, Ming</creator><creator>TAO, Chunlin</creator><scope>EVB</scope></search><sort><creationdate>20221201</creationdate><title>IMIDAZOPYRIDINE DERIVATIVES AS STING AGONISTS</title><author>ZANG, Jingcun ; HSIEH, Ming ; TAO, Chunlin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2022246597A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ZANG, Jingcun</creatorcontrib><creatorcontrib>HSIEH, Ming</creatorcontrib><creatorcontrib>TAO, Chunlin</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZANG, Jingcun</au><au>HSIEH, Ming</au><au>TAO, Chunlin</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>IMIDAZOPYRIDINE DERIVATIVES AS STING AGONISTS</title><date>2022-12-01</date><risdate>2022</risdate><abstract>Described herein, inter alia, are imidazopyridine derivatives (I), pharmaceutically acceptable salts and tautomers thereof, compounds, combinations and medicaments containing said compounds and processes for their preparation. In embodiments, the imidazopyridine derivatives can be used as regulators of a stimulator of interferon genes (STING) and a related signal path thereof, and can effectively treat and/or relieve multiple types of diseases, including but not limited to malignant tumors, inflammations, autoimmune diseases, infectious diseases and as vaccine adjuvants. L'invention concerne, entre autres, des dérivés d'imidazopyridine (I), des sels pharmaceutiquement acceptables et des tautomères de ceux-ci, des composés, des associations et des médicaments contenant lesdits composés et des procédés pour leur préparation. Dans des modes de réalisation, les dérivés d'imidazopyridine peuvent être utilisés en tant que régulateurs d'un stimulateur de gènes d'interféron (STING) et d'une voie de signalisation associée de celui-ci, et peuvent traiter et/ou soulager de manière efficace de multiples types de maladies, y compris mais de façon non limitative des tumeurs malignes, des inflammations, des maladies auto-immunes, des maladies infectieuses et en tant qu'adjuvants de vaccins.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2022246597A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title IMIDAZOPYRIDINE DERIVATIVES AS STING AGONISTS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T05%3A10%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZANG,%20Jingcun&rft.date=2022-12-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2022246597A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true